Comparative Effectiveness of Financial Incentives and Nudges to Reduce Cellphone Use While Driving Among UBI Auto Policy Holders

NCT03833219 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2108

Last updated 2020-09-10

No results posted yet for this study

Summary

The investigators are proposing an experiment to help a national auto insurance company test behavioral economic strategies to reduce the amount of time policy holders actively use their cell phone while driving. Interventions include financial incentives, social comparison, and nudges, and survey data will also be collected. Data collected from this internal trial will be shared with the Penn research team and analyzed

Conditions

  • Automobile Accident

Interventions

BEHAVIORAL

Loss-framed weekly incentive

Send push notification reporting user's handheld phone use while driving compared to distribution for driver cohort (age, geographic area) each week. Pay participant weekly according to where they fall on the distribution each week.

BEHAVIORAL

Weekly feedback

Send push notification reporting user's handheld phone use while driving compared to distribution for driver cohort (age, geographic area) each week.

BEHAVIORAL

End of intervention period incentive

Notify participant about potential incentive at the end of the intervention period, but do not provide weekly feedback about performance.

Sponsors & Collaborators

Principal Investigators

  • M. Kit Delgado, MD, MS · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-07
Primary Completion
2019-10-30
Completion
2020-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833219 on ClinicalTrials.gov